VitaNova Life Sciences (VNOV) Price to Earnings (2022 - 2026)

VitaNova Life Sciences has disclosed Price to Earnings across 4 years of filings, most recently posting 54.02 for Q1 2026.

• Price to Earnings for Q1 2026 came in at 54.02, down 12.68% year-over-year; the trailing twelve-month figure through Jan 2026 was 54.02 (down 12.68% YoY), and the FY2025 annual result was 15.88, down 88.33% from the prior year.
• Price to Earnings for Q1 2026 stood at 54.02, down from 140.02 in the prior quarter.
• Across five years, Price to Earnings topped out at 140.02 in Q4 2025 and bottomed at 15.71 in Q3 2025.
• Average Price to Earnings over 4 years is 77.77, with a median of 64.31 recorded in 2022.
• On a YoY basis, Price to Earnings climbed as much as 56.85% in 2025 and fell as far as 88.33% in 2025.
• Year by year, Price to Earnings stood at 64.31 in 2022, then soared by 38.81% to 89.27 in 2024, then soared by 56.85% to 140.02 in 2025, then sank by 61.42% to 54.02 in 2026.
• The last three Price to Earnings figures came in at 54.02 (Q1 2026), 140.02 (Q4 2025), and 15.71 (Q3 2025), per Business Quant data.